Clinical Trial Update: A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial to evaluate the efficacy and safety of emicizumab in participants with Type 3 von Willebrand disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease Type

Drugs mentioned

• Emicizumab (emicizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Von Willebrand Disease, Type 3 | Phase 3 | Status: RECRUITING